TMO - Thermo Fisher Scientific Inc. (TMO) Q1 2024 Earnings Call Transcript
2024-04-24 11:36:05 ET
Thermo Fisher Scientific Inc. (TMO)
Q1 2024 Earnings Call Transcript
April 24, 2024, 08:30 AM ET
Company Participants
Rafael Tejada - VP, IR
Marc Casper - Chairman, President and CEO
Stephen Williamson - SVP and CFO
Conference Call Participants
Doug Schenkel - Wolfe Research
Mike Ryskin - Bank of America
Jack Meehan - Nephron Research
Rachel Vatnsdal - JPMorgan
Dan Brennan - TD Cowen
Matt Sykes - Goldman Sachs
Luke Sergott - Barclays
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 First Quarter Conference Call. My name is Angela, and I'll be coordinating your call today. [Operator Instructions] I would like to introduce our moderator for the call, Mr. Rafael Tejada, Vice President, Investor Relations. Mr. Tejada, you may begin the call.
Rafael Tejada
Good morning, and thank you for joining us. On the call with me today is Marc Casper, our Chairman, President and Chief Executive Officer, and Stephen Williamson, Senior Vice President and Chief Financial Officer. Please note this call is being webcast live and will be archived on the Investors section of our website thermofisher.com, under the heading News, Events & Presentations until May 8, 2024. A copy of the press release of our first quarter 2024 earnings is available in the Investors section of our website under the heading Financials.
So, before we begin, let me briefly cover our safe harbor statement. Various remarks that we may make about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the company's most recent annual report on Form 10-K, which is on file with the SEC and available in the Investors section of our website under the heading Financials, SEC filings. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so even if our estimates change. Therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.
Also, during this call, we will be referring to certain financial measures not prepared in accordance with generally accepted accounting principles or GAAP. A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures is available in the press release of our first quarter 2024 earnings and also in the Investors section of our website under the heading Financials....
Thermo Fisher Scientific Inc. (TMO) Q1 2024 Earnings Call Transcript